Trial Profile
A study evaluating the safety and efficacy of bevacizumab in combination with XELOX, followed by bevacizumab in combination with XELIRI in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 01 Sep 2015 New trial record